Safety of mr-guided focused ultrasound treatment of pedunculated subserosal uterine leiomyomas

Douglas L. Brown, Gina K. Hesley, Krzysztof R. Gorny, Elizabeth A Stewart

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: There has previously been a concern about whether it is safe to use minimally invasive methods to treat pedunculated subserosal uterine leiomyomas. The purpose of our study is to evaluate the safety of magnetic resonance-guided focused ultrasound (MRgFUS) ablation of pedunculated subserosal uterine leiomyomas. Methods: All cases of MRgFUS ablations performed at our institution from March 2005 through March 2010 were reviewed to identify patients in whom a pedunculated subserosal leiomyoma was treated. Follow-up clinical and surgical data were reviewed to assess for complications. Results: A pedunculated leiomyoma was treated in 11 of 179 patients. Only two of the 11 patients had complications, both of which were minor and likely unrelated specifically to the pedunculated leiomyomas. One patient had transient lumbar plexopathy contralateral to the pedunculated leiomyoma, and one patient had transient voiding difficulty. Operative findings in three other patients who subsequently had myomectomy or hysterectomy found no adhesions or other complications related to the pedunculated leiomyomas. Conclusions: Pedunculated subserosal leiomyomas are not a contraindication to treatment by MRgFUS. We found no evidence of complications specifically related to pedunculated subserosal leiomyomas.

Original languageEnglish (US)
Article number19
JournalJournal of Therapeutic Ultrasound
Volume1
Issue number1
DOIs
StatePublished - Oct 1 2013

Fingerprint

Leiomyoma
Safety
Magnetic Resonance Spectroscopy
Therapeutics
Uterine Myomectomy
Hysterectomy

Keywords

  • Ablation
  • Magnetic resonance
  • Pedunculated leiomyoma
  • Safety
  • Ultrasound
  • Uterus

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Safety of mr-guided focused ultrasound treatment of pedunculated subserosal uterine leiomyomas. / Brown, Douglas L.; Hesley, Gina K.; Gorny, Krzysztof R.; Stewart, Elizabeth A.

In: Journal of Therapeutic Ultrasound, Vol. 1, No. 1, 19, 01.10.2013.

Research output: Contribution to journalArticle

@article{7f0166e708d84872aa1d5dc607bad7fd,
title = "Safety of mr-guided focused ultrasound treatment of pedunculated subserosal uterine leiomyomas",
abstract = "Background: There has previously been a concern about whether it is safe to use minimally invasive methods to treat pedunculated subserosal uterine leiomyomas. The purpose of our study is to evaluate the safety of magnetic resonance-guided focused ultrasound (MRgFUS) ablation of pedunculated subserosal uterine leiomyomas. Methods: All cases of MRgFUS ablations performed at our institution from March 2005 through March 2010 were reviewed to identify patients in whom a pedunculated subserosal leiomyoma was treated. Follow-up clinical and surgical data were reviewed to assess for complications. Results: A pedunculated leiomyoma was treated in 11 of 179 patients. Only two of the 11 patients had complications, both of which were minor and likely unrelated specifically to the pedunculated leiomyomas. One patient had transient lumbar plexopathy contralateral to the pedunculated leiomyoma, and one patient had transient voiding difficulty. Operative findings in three other patients who subsequently had myomectomy or hysterectomy found no adhesions or other complications related to the pedunculated leiomyomas. Conclusions: Pedunculated subserosal leiomyomas are not a contraindication to treatment by MRgFUS. We found no evidence of complications specifically related to pedunculated subserosal leiomyomas.",
keywords = "Ablation, Magnetic resonance, Pedunculated leiomyoma, Safety, Ultrasound, Uterus",
author = "Brown, {Douglas L.} and Hesley, {Gina K.} and Gorny, {Krzysztof R.} and Stewart, {Elizabeth A}",
year = "2013",
month = "10",
day = "1",
doi = "10.1186/2050-5736-1-19",
language = "English (US)",
volume = "1",
journal = "Journal of Therapeutic Ultrasound",
issn = "2050-5736",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Safety of mr-guided focused ultrasound treatment of pedunculated subserosal uterine leiomyomas

AU - Brown, Douglas L.

AU - Hesley, Gina K.

AU - Gorny, Krzysztof R.

AU - Stewart, Elizabeth A

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Background: There has previously been a concern about whether it is safe to use minimally invasive methods to treat pedunculated subserosal uterine leiomyomas. The purpose of our study is to evaluate the safety of magnetic resonance-guided focused ultrasound (MRgFUS) ablation of pedunculated subserosal uterine leiomyomas. Methods: All cases of MRgFUS ablations performed at our institution from March 2005 through March 2010 were reviewed to identify patients in whom a pedunculated subserosal leiomyoma was treated. Follow-up clinical and surgical data were reviewed to assess for complications. Results: A pedunculated leiomyoma was treated in 11 of 179 patients. Only two of the 11 patients had complications, both of which were minor and likely unrelated specifically to the pedunculated leiomyomas. One patient had transient lumbar plexopathy contralateral to the pedunculated leiomyoma, and one patient had transient voiding difficulty. Operative findings in three other patients who subsequently had myomectomy or hysterectomy found no adhesions or other complications related to the pedunculated leiomyomas. Conclusions: Pedunculated subserosal leiomyomas are not a contraindication to treatment by MRgFUS. We found no evidence of complications specifically related to pedunculated subserosal leiomyomas.

AB - Background: There has previously been a concern about whether it is safe to use minimally invasive methods to treat pedunculated subserosal uterine leiomyomas. The purpose of our study is to evaluate the safety of magnetic resonance-guided focused ultrasound (MRgFUS) ablation of pedunculated subserosal uterine leiomyomas. Methods: All cases of MRgFUS ablations performed at our institution from March 2005 through March 2010 were reviewed to identify patients in whom a pedunculated subserosal leiomyoma was treated. Follow-up clinical and surgical data were reviewed to assess for complications. Results: A pedunculated leiomyoma was treated in 11 of 179 patients. Only two of the 11 patients had complications, both of which were minor and likely unrelated specifically to the pedunculated leiomyomas. One patient had transient lumbar plexopathy contralateral to the pedunculated leiomyoma, and one patient had transient voiding difficulty. Operative findings in three other patients who subsequently had myomectomy or hysterectomy found no adhesions or other complications related to the pedunculated leiomyomas. Conclusions: Pedunculated subserosal leiomyomas are not a contraindication to treatment by MRgFUS. We found no evidence of complications specifically related to pedunculated subserosal leiomyomas.

KW - Ablation

KW - Magnetic resonance

KW - Pedunculated leiomyoma

KW - Safety

KW - Ultrasound

KW - Uterus

UR - http://www.scopus.com/inward/record.url?scp=85013766121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013766121&partnerID=8YFLogxK

U2 - 10.1186/2050-5736-1-19

DO - 10.1186/2050-5736-1-19

M3 - Article

AN - SCOPUS:85013766121

VL - 1

JO - Journal of Therapeutic Ultrasound

JF - Journal of Therapeutic Ultrasound

SN - 2050-5736

IS - 1

M1 - 19

ER -